PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.

Heerik, A.S.V.M. van den; Horeweg, N.; Nout, R.A.; Lutgens, L.C.H.W.; Steen-banasik, E.M. van der; Westerveld, G.H.; ... ; Creutzberg, C.L. (2020)

Article / Letter to editor

• All authors: Heerik, A.S.V.M. van den; Horeweg, N.; Nout, R.A.; Lutgens, L.C.H.W.; Steen-banasik, E.M. van der; Westerveld, G.H.; Berg, H.A. van den; Slot, A.; Koppe, F.L.A.; Kommoss, S.; Mens, J.W.M.; Nowee, M.E.; Bijmolt, S.; Cibula, D.; Stam, T.C.; Jurgenliemk-Schulz, I.M.; Snyers, A.; Hamann, M.; Zwanenburg, A.G.; Coen, V.L.M.A.; Vandecasteele, K.; Gillham, C.; Chargari, C.; Verhoeven-Adema, K.W.; Putter, H.; Hout, W.B. van den; Wortman, B.G.; Nijman, H.W.; Bosse, T.; Creutzberg, C.L.
• Date: 2020-08-17
• Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
• Volume: 2020
• Issue: 30
• Pages: 2002 - 2007
• DOI: doi:10.1136/ijgc-2020-001929
• Link: https://ijgc.bmj.com/content/30/12/2002